Next Article in Journal
A Multiplex Test Assessing MiR663ame and VIMme in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions
Next Article in Special Issue
Unmet Medical Needs of Patients with Benign Prostate Enlargement
Previous Article in Journal
Instruments of Choice for Assessment and Monitoring Diabetic Foot: A Systematic Review
Previous Article in Special Issue
Relationship between Lower Urinary Tract Symptoms and Prostatic Urethral Stiffness Using Strain Elastography: Initial Experiences
Open AccessArticle

First Multi-Center All-Comers Study for the Aquablation Procedure

1
Asklepios Westklinikum Hamburg-Rissen, 22559 Hamburg, Germany
2
Tauranga Urology Research Ltd, 3112 Tauranga, New Zealand
3
American University of Beirut Medical Center, 1107 2020 Beirut, Lebanon
4
Royal Melbourne Hospital, Melbourne, Parkville, VIC 3050, Australia
5
Frimley Park Hospital, Trust Lead for Urology, Frimley, Camberley GU16 7UJ, UK
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2020, 9(2), 603; https://doi.org/10.3390/jcm9020603
Received: 3 February 2020 / Revised: 13 February 2020 / Accepted: 18 February 2020 / Published: 24 February 2020
(This article belongs to the Special Issue Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia)
Waterjet-based prostate resection (Aquablation procedure) is an increasingly recognized treatment for symptomatic benign prostatic hyperplasia (BPH). We confirmed the safety and effectiveness of the Aquablation procedure in the commercial setting in 178 men at five sites. The mean prostate volume was 59 cc. The procedure time averaged 24 min and total anesthesia duration was 50 min. The International Prostate Symptom Score (IPSS) decreased from 21.6 at the baseline to 6.5 at the 12-month follow-up, a 15.3-point improvement (p < 0.0001). The maximum urinary flow rate increased from 10 cc/s at the baseline to 20.8 cc/s at month 12 (increase of 11.8 cc, p < 0.0001). Ejaculatory function was relatively preserved. Prostate volume assessed with transrectal ultrasound decreased 36% by month three. Five patients (2.7%) underwent a transfusion in the first week after the procedure. Real-world evidence shows that Aquablation is safe and effective for the treatment of BPH. View Full-Text
Keywords: robotic surgery; benign prostatic hyperplasia; lower urinary tract symptoms robotic surgery; benign prostatic hyperplasia; lower urinary tract symptoms
Show Figures

Figure 1

MDPI and ACS Style

Bach, T.; Gilling, P.; El Hajj, A.; Anderson, P.; Barber, N. First Multi-Center All-Comers Study for the Aquablation Procedure. J. Clin. Med. 2020, 9, 603.

AMA Style

Bach T, Gilling P, El Hajj A, Anderson P, Barber N. First Multi-Center All-Comers Study for the Aquablation Procedure. Journal of Clinical Medicine. 2020; 9(2):603.

Chicago/Turabian Style

Bach, Thorsten; Gilling, Peter; El Hajj, Albert; Anderson, Paul; Barber, Neil. 2020. "First Multi-Center All-Comers Study for the Aquablation Procedure" J. Clin. Med. 9, no. 2: 603.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop